Blanca Scheijen

4.4k total citations · 1 hit paper
53 papers, 2.6k citations indexed

About

Blanca Scheijen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Blanca Scheijen has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Pathology and Forensic Medicine and 16 papers in Oncology. Recurrent topics in Blanca Scheijen's work include Cancer-related gene regulation (15 papers), Lymphoma Diagnosis and Treatment (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Blanca Scheijen is often cited by papers focused on Cancer-related gene regulation (15 papers), Lymphoma Diagnosis and Treatment (13 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Blanca Scheijen collaborates with scholars based in Netherlands, United States and Germany. Blanca Scheijen's co-authors include Anton Berns, Jan Willem Voncken, Maarten van Lohuizen, Jacqueline J.L. Jacobs, Frank N. van Leeuwen, James D. Griffin, Laurens T. van der Meer, Laurensia Yuniati, Peter M. Hoogerbrugge and Roland P. Kuiper and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Genes & Development.

In The Last Decade

Blanca Scheijen

50 papers receiving 2.6k citations

Hit Papers

Bmi-1 collaborates with c-Myc in tumorigenesis by inhibit... 1999 2026 2008 2017 1999 250 500 750

Peers

Blanca Scheijen
Maria Luisa Sulis United States
Woojoong Lee South Korea
Thomas Look United States
Silvia Buonamici United States
Lee N. Lawton United States
Maria Luisa Sulis United States
Blanca Scheijen
Citations per year, relative to Blanca Scheijen Blanca Scheijen (= 1×) peers Maria Luisa Sulis

Countries citing papers authored by Blanca Scheijen

Since Specialization
Citations

This map shows the geographic impact of Blanca Scheijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Blanca Scheijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Blanca Scheijen more than expected).

Fields of papers citing papers by Blanca Scheijen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Blanca Scheijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Blanca Scheijen. The network helps show where Blanca Scheijen may publish in the future.

Co-authorship network of co-authors of Blanca Scheijen

This figure shows the co-authorship network connecting the top 25 collaborators of Blanca Scheijen. A scholar is included among the top collaborators of Blanca Scheijen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Blanca Scheijen. Blanca Scheijen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bekers, Elise M., Astrid Eijkelenboom, J. Han van Krieken, et al.. (2025). Detection of PRKAR1A gene mutations in sporadic cardiac myxomas: a study of 24 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(3). 511–519.
2.
Alfieri, Christina M., et al.. (2023). Btg1 and Btg2 regulate neonatal cardiomyocyte cell cycle arrest. Journal of Molecular and Cellular Cardiology. 179. 30–41. 6 indexed citations
3.
Scheijen, Blanca, et al.. (2022). Next-Generation Sequencing-Based Clonality Detection of Immunoglobulin Gene Rearrangements in B-Cell Lymphoma. Methods in molecular biology. 2453. 7–42. 7 indexed citations
4.
Butler, Miriam, Dorette S. van Ingen Schenau, René Marke, et al.. (2022). Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways. Frontiers in Oncology. 12. 905665–905665. 6 indexed citations
5.
Brand, Michiel van den, Jos Rijntjes, Markus Möbs, et al.. (2021). Next-Generation Sequencing–Based Clonality Assessment of Ig Gene Rearrangements. Journal of Molecular Diagnostics. 23(9). 1105–1115. 23 indexed citations
6.
Brand, Michiel van den, Jos Rijntjes, Konnie M. Hebeda, et al.. (2021). Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements. Modern Pathology. 35(6). 757–766. 12 indexed citations
7.
Scheijen, Blanca. (2019). Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies. Cancer Drug Resistance. 2(3). 647–664. 23 indexed citations
8.
Bekers, Elise M., Danique L. M. van Broekhoven, Thijs van Dalen, et al.. (2018). Multifocal occurrence of extra-abdominal desmoid type fibromatosis – A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case. Annals of Diagnostic Pathology. 35. 38–41. 8 indexed citations
9.
Marke, René, Frank N. van Leeuwen, & Blanca Scheijen. (2018). The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia. Haematologica. 103(4). 565–574. 81 indexed citations
10.
Marke, René, et al.. (2018). Glucocorticoid Resistance in IKZF1-Deleted BCP-ALL: It Is PTEN Again. Blood. 132(Supplement 1). 4088–4088.
11.
Brand, Michiel van den, et al.. (2017). Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma. Journal of Hematopathology. 10(3-4). 91–107. 37 indexed citations
12.
Waanders, Esmé, Blanca Scheijen, Marjolijn C.J. Jongmans, et al.. (2016). Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences. Leukemia. 31(4). 821–828. 38 indexed citations
13.
Tijchon, Esther, et al.. (2015). Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton. PLoS ONE. 10(7). e0131481–e0131481. 11 indexed citations
14.
Ceccarelli, Manuela, Laura Micheli, Giorgio D’Andrea, et al.. (2015). Altered cerebellum development and impaired motor coordination in mice lacking the Btg1 gene: Involvement of cyclin D1. Developmental Biology. 408(1). 109–125. 24 indexed citations
15.
Waanders, Esmé, Blanca Scheijen, Laurens T. van der Meer, et al.. (2012). The Origin and Nature of Tightly Clustered BTG1 Deletions in Precursor B-Cell Acute Lymphoblastic Leukemia Support a Model of Multiclonal Evolution. PLoS Genetics. 8(2). e1002533–e1002533. 59 indexed citations
16.
Tijchon, Esther, et al.. (2012). B-lineage transcription factors and cooperating gene lesions required for leukemia development. Leukemia. 27(3). 541–552. 55 indexed citations
17.
Bussink, Johan, Blanca Scheijen, Irıs D. Nagtegaal, et al.. (2011). Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response. Breast Cancer Research. 13(4). R82–R82. 73 indexed citations
18.
Kuiper, Roland P., Esmé Waanders, Vincent H. J. van der Velden, et al.. (2010). IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. Leukemia. 24(7). 1258–1264. 196 indexed citations
19.
Scheijen, Blanca, et al.. (2004). High Incidence of Thymic Epithelial Tumors in E2F2 Transgenic Mice. Journal of Biological Chemistry. 279(11). 10476–10483. 29 indexed citations
20.
Scheijen, Blanca, Hai T. Ngo, Hyun Kang, & James D. Griffin. (2004). FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins. Oncogene. 23(19). 3338–3349. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026